Tumor Treating Fields (TTFields) Reversibly Permeabilize the Blood–Brain Barrier In Vitro and In Vivo

Despite the availability of numerous therapeutic substances that could potentially target CNS disorders, an inability of these agents to cross the restrictive blood–brain barrier (BBB) limits their clinical utility. Novel strategies to overcome the BBB are therefore needed to improve drug delivery....

Description complète

Détails bibliographiques

Auteurs principaux:	Ellaine Salvador, Almuth F. Kessler, Dominik Domröse, Julia Hörmann, Clara Schaeffer, Aiste Giniunaite, Malgorzata Burek, Catherine Tempel-Brami, Tali Voloshin, Alexandra Volodin, Adel Zeidan, Moshe Giladi, Ralf-Ingo Ernestus, Mario Löhr, Carola Y. Förster, Carsten Hagemann
Format:	Artigo
Langue:	Inglês
Publié:	MDPI AG 2022-09-01
Collection:	Biomolecules
Sujets:	blood–brain barrier TTFields CNS disorders
Accès en ligne:	https://www.mdpi.com/2218-273X/12/10/1348
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!